1. Home
  2. AYTU vs CTNT Comparison

AYTU vs CTNT Comparison

Compare AYTU & CTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • CTNT
  • Stock Information
  • Founded
  • AYTU N/A
  • CTNT 2016
  • Country
  • AYTU United States
  • CTNT United States
  • Employees
  • AYTU N/A
  • CTNT N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • CTNT
  • Sector
  • AYTU Health Care
  • CTNT
  • Exchange
  • AYTU Nasdaq
  • CTNT Nasdaq
  • Market Cap
  • AYTU 10.5M
  • CTNT 9.4M
  • IPO Year
  • AYTU N/A
  • CTNT 2023
  • Fundamental
  • Price
  • AYTU $1.72
  • CTNT $2.45
  • Analyst Decision
  • AYTU
  • CTNT Hold
  • Analyst Count
  • AYTU 0
  • CTNT 1
  • Target Price
  • AYTU N/A
  • CTNT N/A
  • AVG Volume (30 Days)
  • AYTU 27.9K
  • CTNT 82.7K
  • Earning Date
  • AYTU 02-12-2025
  • CTNT 03-17-2025
  • Dividend Yield
  • AYTU N/A
  • CTNT N/A
  • EPS Growth
  • AYTU N/A
  • CTNT N/A
  • EPS
  • AYTU N/A
  • CTNT N/A
  • Revenue
  • AYTU $79,759,000.00
  • CTNT $7,703,113.00
  • Revenue This Year
  • AYTU N/A
  • CTNT N/A
  • Revenue Next Year
  • AYTU N/A
  • CTNT N/A
  • P/E Ratio
  • AYTU N/A
  • CTNT N/A
  • Revenue Growth
  • AYTU N/A
  • CTNT N/A
  • 52 Week Low
  • AYTU $1.30
  • CTNT $1.70
  • 52 Week High
  • AYTU $3.45
  • CTNT $236.16
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 54.22
  • CTNT 39.66
  • Support Level
  • AYTU $1.68
  • CTNT $2.37
  • Resistance Level
  • AYTU $1.93
  • CTNT $2.64
  • Average True Range (ATR)
  • AYTU 0.12
  • CTNT 0.22
  • MACD
  • AYTU 0.00
  • CTNT -0.07
  • Stochastic Oscillator
  • AYTU 36.36
  • CTNT 11.79

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

About CTNT Cheetah Net Supply Chain Service Inc.

Cheetah Net Supply Chain Service Inc is a supplier of parallel-import vehicles sourced in the U.S. to be sold in the China market. The parallel-import vehicles refer to those purchased by dealers directly from overseas markets and imported for sale through channels other than brand manufacturers' official distribution systems. The company purchases automobiles, luxury brands such as Mercedes, BMW, Porsche, Lexus, and Bentley, from the U.S. market and resells them to customers, including both U.S. and PRC parallel-import car dealers. The company derives profits from the price difference between buying and selling prices for parallel-import vehicles.

Share on Social Networks: